China 1243308-37-3 Factory

We insist over the principle of enhancement of 'High high quality, Efficiency, Sincerity and Down-to-earth working approach' to offer you with superb assistance of processing for 1243308-37-3,CAS NO 1243308-37-3,Edoxaban intermediate,Edoxaban advance intermediate,2-[(5-Chloropyridin-2-yl)Amino]-2-Oxoacetic, We have exported to more than 40 countries and regions, which have gained fantastic popularity from our costumers everywhere in the globe.
1243308-37-3, Being the top solutions of our factory, our solutions series have been tested and won us experienced authority certifications. For additional parameters and item list details, be sure to click the button to acquire additional nformation.

Hot Products

  • 1-(4-IODO-PHENYL)-PIPERIDIN-2-ONE

    1-(4-IODO-PHENYL)-PIPERIDIN-2-ONE

    Product Name:1-(4-IODO-PHENYL)-PIPERIDIN-2-ONE
    Molecular Formula:C11H12INO
    Molecular Weight:301.12
    CAS Registry Number:385425-15-0
  • (9S)-9-Amino-9-deoxoerythromycin

    (9S)-9-Amino-9-deoxoerythromycin

    Product Name:(9S)-9-Amino-9-deoxoerythromycin
    Molecular Formula:C37H70N2O12
    Molecular Weight:734.96
    CAS Registry Number:26116-56-3
  • Bis(pinacolato)diboron

    Bis(pinacolato)diboron

    Product Name:Bis(pinacolato)diboron
    Molecular Weight:253.94
    CAS Registry Number:73183-34-3
  • 4-Bromobiphenyl

    4-Bromobiphenyl

    Product Name:4-Bromobiphenyl
    Molecular Formula:C12H9Br
    Molecular Weight:233.1
    CAS Registry Number:92-66-0
  • L-tert-Leucine

    L-tert-Leucine

    Product Name:L-tert-Leucine
    Molecular Formula:C6H13NO2
    Molecular Weight:131.17
    CAS Registry Number:20859-02-3
  • (1R,3S)-3-AMinocyclopentanol hydrochloride

    (1R,3S)-3-AMinocyclopentanol hydrochloride

    Product Name:(1R,3S)-3-AMinocyclopentanol hydrochloride
    Molecular Formula:C5H12ClNO
    Molecular Weight:137.60788
    CAS Registry Number:1279032-31-3

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept